The AI GTM platform for Biotech
Merix is the first AI agent platform dedicated to Biotech commercialization.
Our goal is to make it easier for biotech teams to know what the evidence actually says—and to use it consistently across commercialization.
What Merix changes
From ad-hoc evidence to a governed system.
Merix turns disconnected research, field notes, targeting logic, payer documents, and Commercial Ops analysis into one intelligence layer—so teams can move faster without losing defensibility.
Overview
Commercialization intelligence, powered by AI agents.
Merix is a single intelligence layer for biotech GTM. It brings market research, field and MA evidence, payer policies, targeting logic, and Commercial Ops analysis into one governed system—so teams can align on what the evidence actually supports.
One source of truth for evidence
Stop losing insight to decks, emails, and one-off notes.
- Unify market research with field and MA evidence
- Ask questions across the full corpus with citations
- Reuse evidence across decisions instead of redoing synthesis
Commercial Ops owned, cross-team usable
Built for the team that already owns the workflows.
- Governed access for Marketing, Field, MA, and Access
- Clear provenance and versioning across sources
- Exports that fit how teams actually communicate
Defensible decisions at operating speed
Move fast without losing traceability.
- Explainable targeting and policy monitoring
- Audit trails for key assumptions and outputs
- Decision memos that capture what changed and why
Platform
Six modules, one intelligence layer.
Start with the Evidence Hub and Insight Ops backbone, then add the modules your Commercial Ops team owns today.
Commercialization intelligence layer
demoMerix organizes evidence and operational intelligence into a governed foundation. AI agents operate on top of that layer to answer questions, highlight changes, and support decisions—while teams only see what they’re allowed to see.
- One place for MR, field evidence, targeting logic, payer documents
- Role-based access with auditability
- Outputs designed for real workflows, not demos
Click to see the Intelligence Layer & Evidence Hub demo.
1) Market & Field Evidence Hub + AI Chat Agents
demoAsk questions of market research, field feedback, and MA insights in one place—with citations back to the source evidence.
Click to see the Evidence Hub & chat experience.
2) Insight Ops Pipeline
demoThe operational backbone that keeps the evidence clean, current, and safe to rely on.
Click to explore the Insight Ops Pipeline demo.
3) HCP Targeting & Territory Intelligence
demoPrioritize HCPs, accounts, and territories—and explain why those priorities exist.
Click to explore Territory Intelligence & targeting.
4) Payer Policy Monitoring & Access Intelligence
demoTrack payer policies and access criteria over time so teams see risk early and respond deliberately.
Click to explore the Payer Policy Monitoring demo.
5) Key Opinion Leader & Influence Mapping
demoA shared view of who influences diagnosis and treatment—and a way to preserve that knowledge over time.
Click to explore the Key Opinion Leader & Influence Mapping demo.
6) Commercial Ops Analytics Workbench
demoA shared workspace for incentives, performance questions, and planning inputs—so analysis doesn’t die in spreadsheets.
Click to explore the Commercial Ops Analytics demo.
Merix centralizes evidence, but access stays role-based. AI agents operate inside defined scopes, and key outputs can be reviewed, saved, and audited—so speed doesn’t come at the cost of control.
Use cases
How biotech GTM teams use Merix.
Real workflows for Commercial Ops, Marketing, Field, and Access—built around evidence, not one-off analysis.
Answer high-stakes questions fast
Get a sourced answer without a week of synthesis.
Make targeting explainable
Prioritize HCPs and territories with logic leadership can defend.
Catch access friction early
Track payer criteria changes and share impact quickly.
Security
Built for biotech constraints: privacy, governance, and control.
Merix is designed for sensitive research and commercial data. AI agents operate under your governance model, with role-based access and auditability.
Security controls
Clear safeguards for evidence, operational data, and internal analysis. Designed to support controlled access and defensible outputs.
Deployment options
Choose how and where Merix runs. We adapt to your security posture and governance requirements.
Pricing
Enterprise pricing, aligned to adoption.
Most teams start with the Evidence Hub and Insight Ops backbone, then expand into targeting, access, key opinion leader mapping, and Commercial Ops analytics.
How we typically engage
We start with a narrow scope, prove value quickly, and expand based on the workflows your Commercial Ops team owns.
Team
Built by people who’ve lived GTM, AI, and enterprise constraints.
We build systems that operators actually use: governed data, clear outputs, and adoption-first design.
Previously founded an AI-powered compliance software company and closed six-figure enterprise contracts, including with GoPuff. Focused on building AI products that operators actually adopt.
Built AI systems for a top-20 pharmaceutical company and leads platform architecture and security for Merix.
Ten years of marketing data science experience across Uber, Udacity, and Cisco, with a focus on explainable, practical modeling.
If you’re rethinking biotech GTM with AI, let’s talk.
Bring one market research deliverable, a targeting question, or a payer policy challenge. We’ll show what Merix looks like in your workflow.